Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation

Molecular Endocrinology

Volumn 12, Issue 12, 1998, Pages 1870-1878

  Sarbassov, Dos D ^a   Peterson, Charlotte A ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; ENZYME ACTIVITY; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031756168     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.12.12.0205     Document Type: Article

References (55)

1. Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS 1991 "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 266:15917-15923
2. Stewart CEH, Rotwein P 1996 Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 271:11330-11338
3. Stewart CEH, James PL, Fant ME, Rotwein P 1996 Over-expression of insulin-like growth factor-II induces accelerated myoblast differentiation. J Cell Physiol 169:23-32
4. Rosen KM, Wentworth BM, Rosenthal N, Villa-Komaroff L 1993 Specific, temporally regulated expression of the insulin-like growth factor II gene during muscle cell differentiation. Endocrinology 133:474-481
5. Sarbassov DD, Jones LG, Peterson CA 1997 Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts. Mol Endocrinol 11:2038-2047
6. Olson EN, Klein WH 1994 bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev 8:1-84
7. Florini JR, Ewton DZ 1990 Highly specific inhibition of IGF-I-stimulated differentiation by an antisense oligodeoxyribonucleotide to myogenin mRNA. J Biol Chem 265:13435-13437
8. Kaliman P, Vinals F, Testar X, Palacin M, Zorzano A 1996 Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem 271: 19146-19151
9. Kaliman P, Canicio J, Shepherd PR, Beeton CA, Testar X, Palacin M, Zorzano A 1998 Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Mol Endocrinol 12:66-77
10. Pinset C, Garcia A, Rousse S, Dubois C, Montarras D 1997 Wortmannin inhibits IGF-dependent differentiation in the mouse myogenic cell line C2. C R Acad Sci Paris 320:367-374
11. Milasincic DJ, Calera MR, Farmer SR, Pilch PF 1996 Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways. Mol Cell Biol 16:5964-5973
12. Derman MP, Toker A, Hartwig JH, Spokes K, Falck JR, Chen C-S, Cantley LC, Cantley LG 1995 The lipid products of phosphoinositide 3-kinase mediate chemotaxis through protein kinase. J Biol Chem 272:6465-6470
13. Joly M, Kazlauskas A, Fay F, Corvera S 1994 Disruption of PDGF receptor trafficking by mutation of its Pl-3 kinase binding sites. Science 263:684-687
14. Frevert EU, Kahn BB 1997 Differential effects of constitutively active PI3-K on glucose transport, glycogen synthase activity and DNA synthesis in 3T3-L1 adipocytes. Mol Cell Biol 17:190-198
15. Wennstrom S, Hawkins S, Cooke F, Hara K, Yonezawa K, Kasuga M, Jackson T, Claesson-Welsh L, Stephens L 1994 Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr Biol 4:385-393
16. Yao R, Cooper G 1995 Requirement for phosphatidylinositol-3-kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003-2006
17. Valius M, Kazlauskas A 1993 Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDFG receptor's mitogenic signal. Cell 73:321-334
18. Kundra V, Escobedo J, Kazlaukas A, Kim H, Rhee S, Williams L, Zetter B 1994 Regulation of chemotaxis by the platelet-derived growth factor receptor-Beta. Nature 367:474-476
19. Gold M, Duronio V, Saxena S, Schrader J, Aebersold R 1994 Multiple cytokines activate phosphatidylinositol 3-kinase in hemopoietic cells. J Biol Chem 269:5403-5412
20. Hu P, Margolis B, Skolnik E, Lammers R, Ullrich A, Schlessinger J 1992 Interactions of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol Cell Biol 12:981-990
21. Ruderman N, Kapeller R, White M, Cantley L 1990 Activation of phosphatidylinositol-3-kinase by insulin. Proc Natl Acad Sci USA 87:1411-1415
22. Chung J, Grammer T, Lemon K, Kazlauskas A, Blenis J 1994 PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370:71-75
23. Kapeller R, Prasad K, Jansssen O, Hou W, Schaffhausen B, Rudd C, Cantley L 1994 Identification of two SH3-binding motifs in the regulatory subunit of phosphatidyl-inositol 3-kinase. J Biol Chem 269:1927-1933
24. Songyang Z, Shoelson S, Chaudhuri M, Gish G, Roberts T, Ratnofsky S, Lechleider R, Neel B, Birge R, Fajardo J, et al. 1993 SH2 domains recognized specific phosphopeptide sequences. Cell 72:767-778
25. Backer JM, Myers MG, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis D, Skolnik EY, Schlessinger J, White MF 1992 The phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11:3469-3479
26. Herbst J, Andrews G, Contillo L, Lamphere L, Gardner J, Lienhard G, Gibbs E 1994 Potent activation of phosphatidylinositol 3′-kinase by simple phosphotyrosine pep-tides derived from insulin receptor substrate 1 containing two YMXM motifs for binding SH2 domains. Biochemistry 33:9376-9381
27. Dhand R, Hiles I, Panayotou G, Roche S, Fry M, Gout I, Totty N, Truong O, Vicendo P, Yonezawa K, et al. 1994 PI-3-kinase is a dual specificity enzyme-autoregulation by an intrinsic protein-serine kinase activity. EMBO J 13:511-521
28. Tanti J, Gremeaux T, Obberghen EV, Marchand-Brustel YL 1994 Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem J 304:17-21
29. Ewton DZ, Roof SL, Magri KA, McWade FJ, Florini JR 1994 IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation. J Cell Physiol 16:277-284
30. Florini JR, Ewton DZ, Coolican SA 1996 Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17:481-517
31. Leroith D, Werner H, Beitner-Johnson D, Roberts CT 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
32. Myers Jr MG, Zhang Y, Aldaz GA, Grammar T, Glasheen EM, Yenush L, Wang LM, Sun XJ, Blenis J, Pierce JH, White MF 1996 YMXM motifs and signalling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites. Mol Cell Biol 16:4147-4155
33. Myers MG, Wang L, Sun XJ, Zhang Y, Yenush L, Schlessinger J, Pierce JH, White MF 1994 Role of IRS-1-GRB-2 complexes in insulin signalling. Mol Cell Biol 14:3577-3587
34. Li CH, Li W, Nishimura R, Zhou M, Batzer A, Myers MG, White MF, Schlessinger J, Skolnik EY 1993 Nek associates with SH2 domain docking proteins IRS-1 in insulin stimulated cells. Proc Natl Acad Sei USA 90:11713-11717
35. Kuhne MR, Pawson T, Lienhard GE, Feng G 1993 The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem 268:11479-11481
36. Cheatham B, Kahn CR 1995 Insulin action and the insulin signaling network. Endocr Rev 16:117-142
37. Tanti J, Gremeaux T, Obberghen EV, Marchand-Brustel YL 1994 Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signalling. J Biol Chem 269:6051-6057
38. Myers MG, Backer JM, Sun XJ, Shoelson SE, Hu P, Schlessinger J, Yoakim M, Shaffhausen B, White MF 1992 IRS-1 activates the phosphatidylinositol 3′-kinase by associating with the src homology 2 domains of p85. Proc Natl Acad Sci USA 89:10350-10354
39. Lam K, Carpenter CL, Ruderman NB, Friel JC, Kelly KL 1994 The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. J Biol Chem 269:20648-20652
40. Bennett AM, Tonks NK 1997 Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278:1288-1291
41. Gredinger E, Gerber AN, Tamir Y, Tapscott SJ, Bengal E 1998 Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J Biol Chem 273:10436-10444
42. Sarbassov DD, Stefanova R, Grigoriev VG, Peterson CA 1995 Role of insulin-like growth factors and myogenin in the altered program of proliferation and differentiation in NFB4 mutant muscle cell line. Proc Natl Acad Sci USA 92:10874-10878
43. Hotamisligil G, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α - and obesity-induced insulin resistance. Science 271:665-668
44. Peterson CA, Gordon H, Hall ZW, Paterson BM, Blau HM 1990 Negative control of the helix-loop-helix family of myogenic regulators in the NFB mutant. Cell 62:493-502
45. Sun XJ, Wang L, Zhang Y, Yenush L, Myers MG, Glasheen E, Lane WS, Pierce JH, White MF 1995 Role of IRS-2 in insulin and cytokine signaling. Nature 377:173-177
46. Johnston JA, Wang LM, Hanson EP, Sun XJ, White MF, Oakes SA, Pierce JH, O'Shea JJ 1995 Interleukines 2,4,7 and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. J Biol Chem 270:28527-28530
47. Tollefsen SE, Lajara R, McCusker R, Clemmons DR, Rotwein P 1989 Insulin-like growth factors (IGFs) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. J Biol Chem 264:13810-13817
48. Ito T, Sasaki Y, Wands JR 1996 Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases. Mol Cell Biol 16:943-951
49. Tanaka S, Ito T, Wands JR 1996 Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules. J Biol Chem 271:14610-14616
50. Heasley LE, Johnson GL 1992 The β-PDGF receptor induces neuronal differentiation of PC12 cells. Mol Biol Cell 3:545-553
51. Nguyen TT, Scimeca J-C, Filoux C, Peraldi P, Carpentier J-L, Van Obberghen E 1993 Co-regulation of the mitogen-activated protein kinase, extracellular signal-regulated kinase 1, and the 90-kDa ribosomal S6 kinase in PC12 cells. J Biol Chem 268:9803-9810
52. Duckworth B, Cantley L 1997 Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. J Biol Chem 272:27665-27670
53. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR 1997 The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 272:6653-6662
54. Kain SR, Mai K, Sinai P 1994 Human multiple tissue western blots: a new immunological tool for the analysis of tissue-specific protein expression. Biotechniques 17:982-987
55. Kubota Y, Angelotti T, Niederfellner G, Herbst R, Ullrich A 1998 Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases. Cell Growth Differ 9:247-256